SURF4 maintains stem-like properties via BIRC3 in ovarian cancer cells.

Yongfang Yue Lili Xia Shanshan Xu Conghui Wang Xinyu Wang Weiguo Lü Xing Xie

Published in: Journal of gynecologic oncology (2020)

Our findings suggest that SURF4 possesses the ability to maintain stemness of OCSCs via BIRC3, and may serve as a potential target in stem cell-targeted therapy for ovarian cancer.

Keyphrases

drug delivery
stem cells
cancer therapy
cell therapy
epithelial mesenchymal transition
human health
bone marrow
mesenchymal stem cells